# Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin

> **NCT00603239** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 165 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** exenatide
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00603239
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2015-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00603239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00603239, "Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00603239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*